Suggestions
Imran Nasrullah, MS, JD
Founder | Business Development & Licensing | Intrapreneur | Ecosystem Building | Board Member | Mentor
Imran Nasrullah is a seasoned professional in the biotechnology and pharmaceutical industries, currently serving as an Advisory Board Member at CyGenica.25 With a diverse background spanning over 25 years in business development, licensing, strategy, and economic development, Imran has established himself as a valuable asset in the biotech ecosystem.3
Professional Experience
Imran's career is characterized by his role as an intrapreneur driving external innovation with entrepreneurs.3 He currently holds multiple positions and engages in various activities:
- Advisory Board Member at CyGenica: In this role, he contributes his extensive industry knowledge to guide the company's strategic decisions.25
- Mentor and Advisor: Imran serves as a mentor to early-stage biotech CEOs in the TF fellowship and assists in interviewing and selecting CEOs for the Termeer fellowship.1
- Board Memberships: He is involved with several organizations, including being a Co-Founder of Snap Life Sciences.2
Expertise and Skills
Imran Nasrullah is known for his:
- Expertise in business development and licensing
- Strategic thinking and ecosystem building
- Cross-functional capabilities in the biopharmaceutical sector6
Education and Qualifications
Imran holds advanced degrees that contribute to his comprehensive understanding of the biotech industry:
Recent Activities
As of September 1, 2024, Imran has been active on professional networking platforms, sharing insights on leadership and management needs in the evolving biotech landscape.4 His LinkedIn profile (username: imrannasrullah) reflects his current roles and professional interests.
Imran Nasrullah's multifaceted experience and ongoing involvement in various aspects of the biotech industry make him a valuable advisor and thought leader in the field.
Highlights
The importanced of experienced executives in biotech could not be underscored more. At the macro level, it is why many ecosystems cannot thrive - lack of experienced executives to take a company forward after initial funding. At the micro level, people forged in big pharma and big biotech bring management skills, experiences (operationally, situations, deal-structuring & negotiations) & networks spanning industry, financing, government & other enablers of success).
“If the proposed march-in framework takes effect, industry will avoid commercializing discoveries "tainted" by U.S. government funding -- and not just in the biotech industry. Any intellectual property resulting from government-funded research will be eligible for march-in. The proposal threatens the entire high-tech economy.”
